PlainRecalls
FDA Devices Moderate Class II Terminated

Revogene SARS-CoV-2 Catalog Number: 410700 IVD for real-time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) qualitative test run on the Revogene¿ instrument for the detection of SARS-CoV-2 nucleic acid from nasopharyngeal swab (NPS) specimens from individuals suspected of COVID-19

Reported: May 19, 2021 Initiated: April 8, 2021 #Z-1540-2021

Product Description

Revogene SARS-CoV-2 Catalog Number: 410700 IVD for real-time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) qualitative test run on the Revogene¿ instrument for the detection of SARS-CoV-2 nucleic acid from nasopharyngeal swab (NPS) specimens from individuals suspected of COVID-19

Reason for Recall

Emergency Use Application (EUA) application withdrawn as false negative results reported

Details

Recalling Firm
Meridian Bioscience Inc
Units Affected
376 kits of the Revogene SARS-CoV-2 assay
Distribution
Nationwide
Location
Cincinnati, OH

Frequently Asked Questions

What product was recalled?
Revogene SARS-CoV-2 Catalog Number: 410700 IVD for real-time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) qualitative test run on the Revogene¿ instrument for the detection of SARS-CoV-2 nucleic acid from nasopharyngeal swab (NPS) specimens from individuals suspected of COVID-19. Recalled by Meridian Bioscience Inc. Units affected: 376 kits of the Revogene SARS-CoV-2 assay.
Why was this product recalled?
Emergency Use Application (EUA) application withdrawn as false negative results reported
Which agency issued this recall?
This recall was issued by the FDA Devices on May 19, 2021. Severity: Moderate. Recall number: Z-1540-2021.